Fact CheckerSign in

NCT05430841Completed

Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CT

Source: ClinicalTrials.gov · Last updated 1 Aug 2025

Brief summary (registry, in English)

To evaluate the potential usefulness of 18F-AlF-FAPI positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in gastrointestinal tumors, and compared with 18F-FDG PET/CT.

Status (registry)
Completed
Study type
Interventional
Enrollment
120 (actual)
First submitted
20 Jun 2022
Start date
1 Jun 2022
Primary completion date
31 Oct 2024
Lead sponsor
The First Affiliated Hospital of Xiamen University
NCT number
NCT05430841

What you commit to

  • Study type: Interventional
  • Participants enrolled: 120
  • From 1 Jun 2022 to the primary completion date, 31 Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • patients with non-malignant lesions;

Other

  • patients with pregnancy;
  • the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.

Who the study is looking for

  • adult patients (aged 18 years or order);
  • patients with suspected or newly diagnosed or previously treated gastrointestinal tumors (supporting evidence may include MRI, CT, tumor markers and pathology report);
  • patients who had scheduled both 18F-FDG and 18F-AlF-FAPI PET/CT scans;
  • patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee.

Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
The First Affiliated hospital of Xiamen University
Coordinator of this site? Confirm its status		XiamenChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.